Suppr超能文献

软体动物的生物和化学多样性:海洋软体动物产生的次生代谢物和药用资源。

Molluscan biological and chemical diversity: secondary metabolites and medicinal resources produced by marine molluscs.

机构信息

School of Biological Sciences, Flinders University, GPO Box 2100 Adeliade, 5001, SA, Australia.

出版信息

Biol Rev Camb Philos Soc. 2010 Nov;85(4):757-75. doi: 10.1111/j.1469-185X.2010.00124.x.

Abstract

The phylum Mollusca represents an enormous diversity of species with eight distinct classes. This review provides a taxonomic breakdown of the published research on marine molluscan natural products and the medicinal products currently derived from molluscs, in order to identify priority targets and strategies for future research. Some marine gastropods and bivalves have been of great interest to natural products chemists, yielding a diversity of chemical classes and several drug leads currently in clinical trials. Molluscs also feature prominently in a broad range of traditional natural medicines, although the active ingredients in the taxa involved are typically unknown. Overall secondary metabolites have only been investigated from a tiny proportion (<1%) of molluscan species. At the class level, the number of species subject to chemical studies mirrors species richness and our relative knowledge of the biology of different taxa. The majority of molluscan natural products research is focused within one of the major groups of gastropods, the opisthobranchs (a subgroup of Heterobranchia), which are primarily comprised of soft-bodied marine molluscs. Conversely, most molluscan medicines are derived from shelled gastropods and bivalves. The complete disregard for several minor classes of molluscs is unjustified based on their evolutionary history and unique life styles, which may have led to novel pathways for secondary metabolism. The Polyplacophora, in particular, have been identified as worthy of future investigation given their use in traditional South African medicines and their abundance in littoral ecosystems. As bioactive compounds are not always constitutively expressed in molluscs, future research should be targeted towards biosynthetic organs and inducible defence reactions for specific medicinal applications. Given the lack of an acquired immune system, the use of bioactive secondary metabolites is likely to be ubiquitous throughout the Mollusca and broadening the search field may uncover interesting novel chemistry.

摘要

门 Mollusca 代表了具有八个不同类别的巨大物种多样性。本综述提供了海洋软体动物天然产物已发表研究和当前从软体动物中提取的药用产品的分类学细分,以确定未来研究的优先目标和策略。一些海洋腹足类和双壳类软体动物一直受到天然产物化学家的极大关注,产生了多种化学类和几种目前处于临床试验阶段的药物先导物。软体动物也在广泛的传统天然药物中占有重要地位,尽管所涉及的类群的活性成分通常未知。总体而言,只有一小部分 (<1%) 软体动物物种的次生代谢物被研究过。在科级水平上,接受化学研究的物种数量反映了物种丰富度和我们对不同类群生物学的相对了解。大多数软体动物天然产物研究集中在主要腹足类群之一的后鳃类(异形类的一个亚群)中,它们主要由软体制的海洋软体动物组成。相反,大多数软体动物药物是从有壳腹足类和双壳类动物中提取的。少数软体动物类群完全被忽视是不合理的,因为它们的进化历史和独特的生活方式可能导致次生代谢的新途径。多板纲动物,特别是在南非传统药物中的应用以及在潮间生态系统中的丰富度,被认为值得进一步研究。由于生物活性化合物在软体动物中并非总是组成型表达,因此未来的研究应针对生物合成器官和特定药用应用的诱导防御反应。由于缺乏获得性免疫系统,生物活性次生代谢物的使用可能在整个软体动物中无处不在,扩大搜索范围可能会发现有趣的新化学物质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验